Showing results (461-470 of 525) with videos related to
Sort By:
Pageof 53
Journal of Endourology|July 30, 2024
Management of Kidney Stones in Pregnancy: A Worldwide Survey of Practice PatternsPatrick Juliebø-Jones, Michelle J Semins, Christian Seitz, et al.Minerva Urology and Nephrology|April 15, 2025
Awareness and use of generative AI-powered tools: results of one-year follow-up prospective cross-sectional global surveyFrancesco Cei, Conner Ganjavi, Ethan Layne, et al.European Urology|August 23, 2014
Conditional survival after radical nephroureterectomy for upper tract carcinomaGuillaume Ploussard, Evanguelos Xylinas, Yair Lotan, et al.BJU International|June 7, 2014
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patientsIlaria Lucca, Morgan Rouprêt, Luis Kluth, et al.The Journal of Urology|December 21, 2012
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomyEvanguelos Xylinas, Michael Rink, Vitaly Margulis, et al.World Journal of Urology|October 2, 2010
Gender differences in radical nephroureterectomy for upper tract urothelial carcinomaShahrokh F Shariat, Ricardo L Favaretto, Amit Gupta, et al.Urologic Oncology|October 12, 2010
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinomaHans-Martin Fritsche, Giacomo Novara, Maximilian Burger, et al.World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.Scientific Reports|November 15, 2018
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosisA K M Ashiqul Haque, Alexander Dewerth, Justin S Antony, et al.Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.Pageof 53